A detailed map of brain cells in Alzheimer's and related dementias

A multimodal brain cell atlas and community resource of Alzheimer's disease and comorbid dementias.

NIH-funded research Allen Institute · NIH-11095671

Building a comprehensive, publicly shared map of how brain cell types and their molecular signatures change in people with Alzheimer's and related dementias to help researchers find new targets and tests.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAllen Institute NIH-funded
Lab location1 site (Seattle, United States)
Project IDNIH-11095671 on NIH RePORTER

What this research studies

From a patient's perspective, this project creates a detailed map showing which brain cells change during Alzheimer's and other dementias. Scientists analyze donated postmortem human brain tissue using single-cell and spatial genomics methods (for example, RNA profiling and ATAC-seq) to see cell-type specific molecular and epigenetic patterns across brain regions and stages of disease. The team will combine these multimodal datasets into an open-access atlas and tools so researchers everywhere can explore the data. The work builds on prior SEA-AD efforts and expands to include comorbid dementias and broader reference data from the BRAIN Initiative.

Who could benefit from this research

Good fit: Adults diagnosed with Alzheimer's disease or related dementias, and people willing to donate brain tissue or clinical data, are the primary sources of material for this work.

Not a fit: People looking for immediate changes to their clinical care or direct treatment benefits are unlikely to gain direct benefit from this resource in the short term.

Why it matters

Potential benefit: If successful, the atlas could speed discovery of disease mechanisms, biomarkers, and new therapeutic targets for Alzheimer's and related dementias.

How similar studies have performed: Earlier SEA-AD work and other single-cell brain atlases have produced large datasets and begun to reveal vulnerable cell types, and this project scales and expands that approach to more brain regions and comorbid dementias.

Where this research is happening

Seattle, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.